Integrin αvβ3 as a target in the prevention of neointimal hyperplasia
Open Access
- 30 June 2007
- journal article
- review article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 45 (6), A33-A38
- https://doi.org/10.1016/j.jvs.2007.02.069
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Characterization of neointima lesions associated with arteriovenous fistulas in a mouse modelKidney International, 2006
- Metastatic PotentialCell, 2003
- IntegrinsCell, 2002
- Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of αvβ3 receptor blockadeAtherosclerosis, 2002
- The β3 Integrin Antagonist m7E3 Reduces Matrix Metalloproteinase Activity and Smooth Muscle Cell MigrationJournal of Vascular Research, 2001
- Functional activation of integrin ?v?3 in tumor cells expressing membrane-type 1 matrix metalloproteinaseInternational Journal of Cancer, 2000
- Effects of β3-Integrin Blockade (c7E3) on the Response to Angioplasty and Intra-Arterial Stenting in Atherosclerotic Nonhuman PrimatesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.JCI Insight, 1995
- Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosisCardiovascular Research, 1994
- Arg-Gly-Asp: A versatile cell recognition signalCell, 1986